Results Of A Large Open-Label Safety Study Of Daxibotulinumtoxina For Injection In Glabellar Lines
Journal of The American Academy of Dermatology(2020)
摘要
Introduction: A large open-label safety study of daxibotulinumtoxina for Injection (DAXI) assessed safety and efficacy with longer-term use and across successive glabellar lines (GL) treatment cycles.
更多查看译文
关键词
daxibotulinumtoxina,glabellar lines,injection,open-label
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要